Table II.
χ2 test of clinicopathological factors and CD117 expression.
| Sample size (%) | |||
|---|---|---|---|
| Characteristics | CD117- | CD117+ | P-value |
| Age (years) | 0.957 | ||
| ≤69 | 44 (44.4) | 9 (9.1) | |
| >69 | 38 (38.4) | 8 (8.1) | |
| Gender | 0.036 | ||
| Male | 45 (45.5) | 14 (14.1) | |
| Female | 37 (37.4) | 3 (3.0) | |
| Maximum tumor size | 0.897 | ||
| ≤26 | 42 (42.4) | 9 (9.1) | |
| >26 | 40 (40.4) | 8 (8.1) | |
| Lymph node metastasis | 0.254 | ||
| Negative | 62 (62.6) | 15 (15.2) | |
| Positive | 20 (20.2) | 2 (2.0) | |
| Pleural invasion | 0.746 | ||
| Negative | 61 (61.6) | 12 (12.1) | |
| Positive | 21 (21.2) | 5 (5.1) | |
| Lymphatic invasion | 0.778 | ||
| Negative | 22 (22.2) | 4 (4.0) | |
| Positive | 60 (60.6) | 13 (13.1) | |
| Venous invasion | 0.349 | ||
| Negative | 44 (44.4) | 7 (7.1) | |
| Positive | 38 (38.4) | 10 (10.1) | |
| Pathological stage | 0.375 | ||
| Stage I | 59 (59.6) | 14 (14.1) | |
| Stage II/III | 23 (23.2) | 3 (3.0) | |
| Histological type | 0.352 | ||
| Ad | 62 (62.6) | 11 (11.1) | |
| Sq | 20 (20.2) | 6 (6.1) | |
| Differentiation | 0.693 | ||
| Well | 18 (18.2) | 3 (3.0) | |
| Moderately/poorly | 64 (64.6) | 14 (14.1) | |
| Recurrence | <0.001 | ||
| Absence | 75 (75.8) | 10 (10.1) | |
| Presence | 7 (7.1) | 7 (7.1) | |
Ad, adenocarcinoma; Sq, squamous carcinoma; CD, cluster of differentiation. Age and maximum tumor size were divided into two categories according to the median line.